Erythromycin
NDC 71209-100, Erythromycin, tablet, film coated, from Cadila Pharmaceuticals Limited.
- Product NDC
- 71209-100
- Status
- Listed
- Labeler
- Cadila Pharmaceuticals Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213628
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71209-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERYTHROMYCIN250 mg/1
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71209-100-01 | 71209010001 | 30 TABLET, FILM COATED in 1 BOTTLE (71209-100-01) |
| 71209-100-05 | 71209010005 | 100 TABLET, FILM COATED in 1 BOTTLE (71209-100-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fae8fc38-3c60-43b8-a0f9-2c50df332505
Use it
Look up 71209-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71209-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71209-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.